01
Oncology
Solid tumours and radiation oncology, supported by hematology and imaging partners.
Therapeutic areas
Nine research lines. One scientific focus.
Our investigators cover a broad multi-therapeutic portfolio, anchored by deep experience in tropical and infectious disease.
-
- 02
Neurology
Neurological protocols across the adult population.
- 03
Cardiology
Cardiovascular studies with a dedicated investigator.
- 04
Orthopaedics
Musculoskeletal and post-surgical research.
- 05
Epidemiology
Population and observational research across the Caribbean region.
- 06
Pulmonology
Respiratory disease, with two pulmonology investigators on the team.
- 07
Nephrology
Renal disease protocols, including dialysis-adjacent populations.
- 08
Rheumatology
Inflammatory and autoimmune disease, including chikungunya-associated chronic arthritis.
- 09
Infectious Diseases
Arboviral, viral and bacterial disease — our strongest scientific line.
Where we are strongest
Tropical & infectious disease.
Barranquilla sits in an endemic zone for dengue, Zika and chikungunya. That is not a marketing line — it is the epidemiology of the region, and it means naive and exposed populations are reachable for vaccine and therapeutic studies without importing a cohort.
Our investigators have published on:
- Dengue and Zika vaccine research
- Congenital Zika syndrome
- Neutralizing antibody response
- Chronic arthritis associated with chikungunya
We also work across HIV, tuberculosis and hepatitis.
- Dengue
- Zika
- Chikungunya
- HIV
- Tuberculosis
- Hepatitis
